The alcohol use disorder and associated disabilities interview schedule (AUDADIS): Reliability of alcohol and drug modules in a clinical sample
The alcohol use disorder and associated disabilities interview schedule (AUDADIS): Reliability of alcohol and drug modules in a clinical sample
复制标题
DOI：
10.1016/s0376-8716(97)01332-x
复制
发表时间：
1997-03-14
影响因子：
4.2
通讯作者：
Grant, BF
中科院分区：
文献类型：
--
作者：
Hasin, D;Carpenter, KM;Grant, BF
酒精使用障碍和相关残疾访谈表 (AUDADIS) 专为一般人群使用而设计，之前在家庭居民样本中显示出良好的可靠性。然而，临床样本中的测量问题有所不同。因此，我们对 AUDADIS 进行了一项临床样本的再测试研究，该样本来自 296 名物质使用患者，这些患者来自物质和精神学确定的治疗环境。对于高流行率和低流行率药物类别，当前特定药物 AUDADIS 依赖性诊断的可靠性为良好到极好。滥用诊断的可靠性并不那么好，尽管这是由于滥用诊断本身的分层性质，而不是其定义标准。研究了人口统计和其他因素对酒精和可卡因诊断可靠性的潜在影响；低严重性是这两个类别不可靠性的唯一一致预测指标。消费变量的可靠性总体良好，但有一些值得注意的例外。结果表明，AUDADIS 可用于比较酒精和药物诊断个体的治疗样本和社区样本的研究。 (C) 1997 爱思唯尔科学爱尔兰有限公司
The alcohol use disorder and associated disabilities interview schedule (AUDADIS), was designed for use in the general population, and was previously shown to have good reliability in a sample of household residents. However, measurement problems are different in clinical samples. Thus, a test-retest study was conducted of the AUDADIS in a clinical sample of 296 substance-using patients from substance- and psychiatrically-identified treatment settings. Reliability for current drug-specific AUDADIS dependence diagnoses was good to excellent for high-prevalence as well as low-prevalence drug categories. Reliability for abuse diagnoses was not as good, although this was due to the hierarchical nature of the abuse diagnosis itself, rather than its defining criteria. Demographic and other factors were investigated for their potential effects on the reliability of alcohol and cocaine diagnoses; low severity was the only consistent predictor of unreliability for both of these categories. Reliability of consumption variables was generally good, with a few notable exceptions. Results suggest that the AUDADIS can be used in research comparing treated to community samples of individuals with alcohol and drug diagnoses. (C) 1997 Elsevier Science Ireland Ltd.